Evidence map›Paper›PMID 33294268›Full record

ArticleAmerican journal of cancer research2020

Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma: a large population-based study.

Zihan Xu, Li Wang, Li Tu, Yanyang Liu, Xiaoxiao Xie, Xiaojun Tang, Feng Luo

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zihan XuLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, China.
Li WangLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, China.
Li TuLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, China.
Yanyang LiuLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, China.
Xiaoxiao XieLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, China.
Xiaojun TangLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, China.
Feng LuoLung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University Chengdu, Sichuan, China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcomatoid carcinoma (SC) is regarded as a rare malignant neoplasm associated with poor outcomes. This study aimed to explore the epidemiological characteristics and prognostic factors of SC, and establish a clinical predictive model. The Surveillance, Epidemiology, and End Results database was used for data inquiry of patients with SC. Relevant population materials were used for age-adjusted incidence, limited-duration prevalence and prognostic analyses, and also for nomogram construction and validation. A total of 17,917 cases of SC were identified. Among them, 12,276 (68.52%) were women and 14,265 (79.62%) were white. Most cases occurred in the female genital system, accounting for 41.10% of all SCs. The median age at diagnosis was 68 years. The incidence and prevalence of SC increased substantially over time. The age-adjusted incidence increased from 0.31/100,000 in 1973 to 1.26/100,000 by 2014, a 4.06-fold change. Among site groups, the incidence of SC in the female genital and the respiratory system increased most significantly (

Indexed as

Epidemiologyincidencenomogramprognosissarcomatoid carcinomaSEER

Identifiers

PMID33294268
PMCPMC7716166
OpenAlexW3112088510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.